These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12825795)

  • 1. Development of biologically active compounds by combining 3D QSAR and structure-based design methods.
    Sippl W
    J Comput Aided Mol Des; 2002 Nov; 16(11):825-30. PubMed ID: 12825795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-based 3D QSAR analysis of estrogen receptor ligands--merging the accuracy of receptor-based alignments with the computational efficiency of ligand-based methods.
    Sippl W
    J Comput Aided Mol Des; 2000 Aug; 14(6):559-72. PubMed ID: 10921772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
    Pandey G; Saxena AK
    J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding affinity prediction of novel estrogen receptor ligands using receptor-based 3-D QSAR methods.
    Sippl W
    Bioorg Med Chem; 2002 Dec; 10(12):3741-55. PubMed ID: 12413831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based 3D QSAR and design of novel acetylcholinesterase inhibitors.
    Sippl W; Contreras JM; Parrot I; Rival YM; Wermuth CG
    J Comput Aided Mol Des; 2001 May; 15(5):395-410. PubMed ID: 11394735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenging the gold standard for 3D-QSAR: template CoMFA versus X-ray alignment.
    Wendt B; Cramer RD
    J Comput Aided Mol Des; 2014 Aug; 28(8):803-24. PubMed ID: 24934658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of 3D-QSAR Model for Acetylcholinesterase Inhibitors Using a Combination of Fingerprint, Molecular Docking, and Structure-Based Pharmacophore Approaches.
    Lee S; Barron MG
    Toxicol Sci; 2015 Nov; 148(1):60-70. PubMed ID: 26202430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of variable docking conditions and scoring functions on corresponding protein-aligned comparative molecular field analysis models constructed from diverse human protein tyrosine phosphatase 1B inhibitors.
    Taha MO; AlDamen MA
    J Med Chem; 2005 Dec; 48(25):8016-34. PubMed ID: 16335926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
    Rao GS; Ramachandran MV; Bajaj JS
    J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative structure-activity relationship (QSAR) and design of novel ligands that demonstrate high potency and target selectivity as protein tyrosine phosphatase 1B (PTP 1B) inhibitors as an effective strategy used to model anti-diabetic agents.
    Arthur DE; Ejeh S; Uzairu A
    J Recept Signal Transduct Res; 2020 Dec; 40(6):501-520. PubMed ID: 32397858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D-QSAR and receptor modeling of tyrosine kinase inhibitors with flexible atom receptor model (FLARM).
    Peng T; Pei J; Zhou J
    J Chem Inf Comput Sci; 2003; 43(1):298-303. PubMed ID: 12546565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D-QSAR CoMFA and CoMSIA on protein tyrosine phosphatase 1B inhibitors.
    Murthy VS; Kulkarni VM
    Bioorg Med Chem; 2002 Jul; 10(7):2267-82. PubMed ID: 11983524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
    Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer-aided molecular design of highly potent HIV-1 RT inhibitors: 3D QSAR and molecular docking studies of efavirenz derivatives.
    Pungpo P; Saparpakorn P; Wolschann P; Hannongbua S
    SAR QSAR Environ Res; 2006 Aug; 17(4):353-70. PubMed ID: 16920659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular docking and 3D-QSAR on 2-(oxalylamino) benzoic acid and its analogues as protein tyrosine phosphatase 1B inhibitors.
    Zhou M; Ji M
    Bioorg Med Chem Lett; 2005 Dec; 15(24):5521-5. PubMed ID: 16230012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-induced conformational changes: improved predictions of ligand binding conformations and affinities.
    Frimurer TM; Peters GH; Iversen LF; Andersen HS; Møller NP; Olsen OH
    Biophys J; 2003 Apr; 84(4):2273-81. PubMed ID: 12668436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening.
    Taha MO; Bustanji Y; Al-Bakri AG; Yousef AM; Zalloum WA; Al-Masri IM; Atallah N
    J Mol Graph Model; 2007 Mar; 25(6):870-84. PubMed ID: 17035054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D-QSAR methods on the basis of ligand-receptor complexes. Application of COMBINE and GRID/GOLPE methodologies to a series of CYP1A2 ligands.
    Lozano JJ; Pastor M; Cruciani G; Gaedt K; Centeno NB; Gago F; Sanz F
    J Comput Aided Mol Des; 2000 May; 14(4):341-53. PubMed ID: 10815771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multitemplate alignment method for the development of a reliable 3D-QSAR model for the analysis of MMP3 inhibitors.
    Tuccinardi T; Ortore G; Santos MA; Marques SM; Nuti E; Rossello A; Martinelli A
    J Chem Inf Model; 2009 Jul; 49(7):1715-24. PubMed ID: 19522467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.